Glimepiride Aurobindo (Glimepiride)

Glimepiride Aurobindo is indicated for the oral treatment of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient to achieve glycemic control.

• Adjunct to lifestyle modifications in adults with type 2 diabetes.
• Used when monotherapy with metformin does not achieve target HbA1c.
• Can be combined with other oral antidiabetic agents such as DPP‑4 inhibitors.
• May be prescribed for patients with stable renal function and no history of severe hypoglycemia.
• Intended for chronic management, not for acute hyperglycemic crises.

The safety profile of Glimepiride Aurobindo includes both frequently observed reactions and less common but potentially serious events.

Common

• Mild to moderate hypoglycemia, especially after missed meals.
• Weight gain due to increased insulin activity.
• Nausea or abdominal discomfort.
• Headache.
• Dizziness or light‑headedness.

Serious

• Severe hypoglycemia requiring assistance.
• Allergic reactions such as rash, pruritus, or angioedema.
• Elevated liver enzymes indicating hepatic stress.
• Blood dyscrasias including neutropenia or thrombocytopenia.

Before initiating Glimepiride Aurobindo, clinicians should evaluate several clinical factors to minimize risk.

• Assess renal and hepatic function; dose may need adjustment in impairment.
• Avoid use in patients with known sulfonylurea hypersensitivity.
• Caution in elderly patients due to increased hypoglycemia risk.
• Monitor blood glucose regularly, especially when initiating or changing dose.
• Educate patients about signs of hypoglycemia and appropriate management.
• Pregnancy and lactation status should be reviewed; safety data are limited.

Glimepiride Aurobindo can interact with other medicines, affecting blood glucose levels or drug metabolism.

Avoid

• Concurrent use with other sulfonylureas or insulin may cause severe hypoglycemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) can increase glimepiride concentrations.
• Beta‑blockers may mask hypoglycemia symptoms.

Use with caution

• Combination with thiazolidinediones may enhance hypoglycemic effect.
• Concurrent use of diuretics may affect potassium balance, influencing glucose control.
• Alcohol intake can potentiate hypoglycemia, especially with large amounts.